+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
FeLV Vaccine Market - Global Forecast 2026-2032- Product Image
FeLV Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

FeLV Vaccine Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147164
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The FeLV Vaccine Market is projected to reach USD 477.54 Million in 2026. It is expected to continue growing at a CAGR of 7.92%, reaching USD 755.42 Million by 2032.

FeLV Vaccine: Executive Summary and Strategic Context

Feline leukemia virus (FeLV) vaccination is an important component of preventive feline healthcare, particularly for cats with outdoor access, contact with infected or status-unknown animals, or other exposure risks. The clinical value of vaccination depends on appropriate risk assessment, testing practices, product handling, and adherence to veterinary guidance. Decisions should also account for age, health status, local epidemiology, and the distinction between core and risk-based vaccination recommendations.

Risk-Based Prevention Is Reshaping FeLV Vaccination

The FeLV vaccine landscape is shifting toward individualized prevention rather than uniform administration. Veterinary protocols increasingly emphasize identifying exposure pathways, testing cats before vaccination when appropriate, maintaining accurate records, and reviewing schedules as a cat’s lifestyle changes. Shelter medicine, multi-cat households, rescue activity, and responsible outdoor access remain important settings for prevention. Education on transmission, quarantine, testing, and vaccination is central to reducing avoidable exposure.

Artificial Intelligence Is Strengthening FeLV Decisions and Delivery

Artificial intelligence can support FeLV prevention by helping practices identify vaccination gaps, segment patients by exposure risk, automate reminders, and detect patterns in clinical and shelter records. Decision-support tools may also assist with interpreting histories and prioritizing follow-up testing, provided that outputs are reviewed by qualified veterinary professionals. Effective adoption requires representative data, privacy safeguards, transparent validation, and careful controls against inappropriate recommendations. AI should augment, not replace, clinical judgment and owner communication.

Regional Insights: Prevention Priorities Differ by Veterinary Infrastructure

In North America, established companion-animal practices and shelter networks support structured testing and risk-based vaccination. Latin America combines growing veterinary access with uneven availability of preventive services, making affordability, outreach, and education important. Europe benefits from developed clinical guidance and regulatory systems, while prevention strategies vary with national practice patterns and outdoor-cat populations. The Middle East presents differing levels of veterinary infrastructure and pet ownership, increasing the value of adaptable education and access programs. Africa requires approaches suited to diverse healthcare capacity, community-animal settings, and supply conditions. Asia-Pacific spans highly developed urban markets and rapidly expanding companion-animal sectors, creating opportunities for stronger screening, recordkeeping, and preventive-care integration.

Group Insights: Multilateral and Economic Blocs Shape Access and Standards

ASEAN countries can benefit from coordinated veterinary education, improved cold-chain reliability, and harmonized approaches to testing and vaccination. BRICS members encompass varied disease-control systems, so collaboration on laboratory capacity, professional training, and responsible access can support broader prevention. The European Union’s regulatory coordination and professional networks facilitate consistent quality and pharmacovigilance practices. G7 economies generally have strong clinical infrastructure, creating opportunities to advance data-driven prevention and shelter protocols. GCC countries may focus on veterinary capacity, import continuity, and awareness in rapidly growing pet-care environments. NATO members span diverse national systems, but shared preparedness principles and cross-border veterinary cooperation can support continuity of preventive services.

Country Insights: National Practice and Access Conditions Matter

Australia’s extensive veterinary network supports risk-based vaccination, with attention to outdoor and multi-cat exposure. Brazil and Mexico can benefit from expanded preventive-care access, education, and shelter partnerships. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain have established companion-animal services where consistent risk assessment, testing, and record management can strengthen outcomes. China and India represent diverse veterinary environments in which urbanization, education, affordability, and service availability influence uptake. Japan and South Korea have sophisticated pet-care sectors that can support digital reminders, standardized records, and preventive counseling. Russia’s geographically varied veterinary infrastructure makes dependable distribution, professional training, and locally appropriate outreach important.

Actionable Priorities for FeLV Vaccine Industry Leaders

Industry leaders should align products and educational materials with current veterinary guidance, clearly communicate appropriate use, and support reliable storage and administration practices. Partnerships with clinics, shelters, laboratories, public-health educators, and animal-welfare organizations can improve testing and follow-up. Digital tools should prioritize reminder systems, verified clinical information, and interoperability with practice records. Organizations should also strengthen pharmacovigilance, monitor access barriers, tailor programs to regional conditions, and measure practical outcomes such as testing completion, schedule adherence, and informed owner engagement without overstating vaccine performance.

Research Methodology for the FeLV Vaccine Executive Summary

This executive summary uses a qualitative, evidence-led framework focused on established principles of FeLV prevention, veterinary practice, healthcare delivery, and responsible technology adoption. The analysis organizes implications across the required regions, economic and political groups, and countries, while avoiding unsupported numerical claims. Interpretation should be validated against current national guidelines, regulatory documents, peer-reviewed veterinary literature, surveillance findings, and local product information before informing clinical, commercial, or policy decisions.

Conclusion: Integrate Vaccination With Testing and Risk Management

FeLV vaccination is most effective as part of a broader prevention strategy that combines exposure assessment, appropriate testing, veterinary consultation, recordkeeping, and owner education. Regional and national differences make flexible implementation essential, while AI offers practical support for identifying gaps and coordinating care when governed responsibly. Leaders who prioritize evidence-based communication, reliable access, professional collaboration, and measurable preventive-care processes will be better positioned to strengthen FeLV control across diverse feline populations.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. FeLV Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Live Attenuated Vaccine
7.3. Recombinant Vaccine
7.4. Subunit Vaccine
8. FeLV Vaccine Market, by Administration Route
8.1. Introduction
8.2. Intramuscular
8.3. Subcutaneous
9. FeLV Vaccine Market, by Form
9.1. Introduction
9.2. Liquid
9.3. Lyophilized
10. FeLV Vaccine Market, by Dosage
10.1. Introduction
10.2. Multi Dose
10.3. Single Dose
11. FeLV Vaccine Market, by End User
11.1. Introduction
11.2. Research Centers
11.3. Veterinary Clinics
11.4. Veterinary Hospitals
12. FeLV Vaccine Market, by Distribution Channel
12.1. Introduction
12.2. Online Stores
12.2.1. E Pharmacy
12.2.2. Manufacturer Website
12.3. Veterinary Clinics
12.4. Veterinary Hospitals
13. FeLV Vaccine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. FeLV Vaccine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. FeLV Vaccine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bioveta a.s.
17.2. Boehringer Ingelheim International GmbH
17.3. Ceva Santé Animale S.A.
17.4. Dechra Pharmaceuticals PLC
17.5. Elanco Animal Health Incorporated
17.6. Heska Corporation
17.7. Hester Biosciences Limited
17.8. HIPRA S.A.
17.9. IDEXX Laboratories Inc.
17.10. Indian Immunologicals Ltd.
17.11. Merck & Co. Inc.
17.12. Phibro Animal Health Corporation
17.13. Vetoquinol S.A.
17.14. Virbac S.A.
17.15. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global FeLV Vaccine Market, Years Considered for the Study
FIGURE 2. Global FeLV Vaccine Market, Research Design
FIGURE 3. Global FeLV Vaccine Market, Research Framework
FIGURE 4. Global FeLV Vaccine Market, Data Triangulation
FIGURE 5. Global FeLV Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global FeLV Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global FeLV Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global FeLV Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 9. Global FeLV Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global FeLV Vaccine Market Size, by Form, 2025 vs 2032 (%)
FIGURE 11. Global FeLV Vaccine Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global FeLV Vaccine Market Size, by Dosage, 2025 vs 2032 (%)
FIGURE 13. Global FeLV Vaccine Market Size, by Dosage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global FeLV Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global FeLV Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global FeLV Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global FeLV Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global FeLV Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global FeLV Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global FeLV Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global FeLV Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global FeLV Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global FeLV Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global FeLV Vaccine Market Segmentation & Coverage
TABLE 2. Global FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Subunit Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Subunit Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Subunit Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 14. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 21. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 28. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 35. Global Research Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Research Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Research Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 45. Global Online Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Online Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Online Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global E Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global E Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global E Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Manufacturer Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Manufacturer Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Manufacturer Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 69. North America FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 71. North America FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 72. North America FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 73. North America FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 74. North America FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. North America FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. North America FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 77. Latin America FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 79. Latin America FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 80. Latin America FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 81. Latin America FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 82. Latin America FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Latin America FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 85. Europe FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 87. Europe FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 88. Europe FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 89. Europe FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 90. Europe FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Europe FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Europe FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 93. Middle East FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 95. Middle East FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 96. Middle East FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 97. Middle East FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 98. Middle East FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Middle East FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Middle East FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 101. Africa FeLV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 103. Africa FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 104. Africa FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 105. Africa FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 106. Africa FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Africa FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Africa FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 109. Global FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 112. ASEAN FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 113. ASEAN FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 114. ASEAN FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 115. ASEAN FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. ASEAN FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. ASEAN FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 118. GCC FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 120. GCC FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 121. GCC FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 122. GCC FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 123. GCC FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. GCC FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. GCC FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 126. European Union FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 128. European Union FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 129. European Union FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 130. European Union FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 131. European Union FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. European Union FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. European Union FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 134. BRICS FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. BRICS FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. BRICS FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 137. BRICS FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 138. BRICS FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 139. BRICS FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. BRICS FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. BRICS FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 142. G7 FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. G7 FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 144. G7 FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 145. G7 FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 146. G7 FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 147. G7 FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. G7 FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. G7 FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 150. NATO FeLV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 152. NATO FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 153. NATO FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 154. NATO FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 155. NATO FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. NATO FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. NATO FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 158. Global FeLV Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 160. United States FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 161. United States FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 162. United States FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 163. United States FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 164. United States FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. United States FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. United States FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 167. Canada FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 168. Canada FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 169. Canada FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 170. Canada FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 171. Canada FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 172. Canada FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Canada FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Canada FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 175. Mexico FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 176. Mexico FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 177. Mexico FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 178. Mexico FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 179. Mexico FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 180. Mexico FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Mexico FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Mexico FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 183. Brazil FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 184. Brazil FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 185. Brazil FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 186. Brazil FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 187. Brazil FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 188. Brazil FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Brazil FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Brazil FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 191. United Kingdom FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 192. United Kingdom FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 193. United Kingdom FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 194. United Kingdom FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 195. United Kingdom FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 196. United Kingdom FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. United Kingdom FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. United Kingdom FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 199. Germany FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 200. Germany FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 201. Germany FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 202. Germany FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 203. Germany FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 204. Germany FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Germany FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Germany FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 207. France FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 208. France FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 209. France FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 210. France FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 211. France FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 212. France FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. France FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. France FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 215. Russia FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 216. Russia FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 217. Russia FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 218. Russia FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 219. Russia FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 220. Russia FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Russia FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Russia FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 223. Italy FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 224. Italy FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 225. Italy FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 226. Italy FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 227. Italy FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 228. Italy FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Italy FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Italy FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 231. Spain FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 232. Spain FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 233. Spain FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 234. Spain FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 235. Spain FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 236. Spain FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Spain FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Spain FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 239. China FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 240. China FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 241. China FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 242. China FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 243. China FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 244. China FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. China FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. China FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 247. India FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 248. India FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 249. India FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 250. India FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 251. India FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 252. India FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. India FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. India FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 255. Japan FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 256. Japan FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 257. Japan FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 258. Japan FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 259. Japan FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 260. Japan FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Japan FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Japan FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 263. Australia FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 264. Australia FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 265. Australia FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 266. Australia FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 267. Australia FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 268. Australia FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Australia FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Australia FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 271. South Korea FeLV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 272. South Korea FeLV Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 273. South Korea FeLV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 274. South Korea FeLV Vaccine Market Size, by Form, 2017-2032 (USD Million)
TABLE 275. South Korea FeLV Vaccine Market Size, by Dosage, 2017-2032 (USD Million)
TABLE 276. South Korea FeLV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. South Korea FeLV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. South Korea FeLV Vaccine Market Size, by Online Stores, 2017-2032 (USD Million)
TABLE 279. Global FeLV Vaccine Market Share, by Key Player, 2025
TABLE 280. Global FeLV Vaccine Market, Key Experts

Companies Mentioned

  • Bioveta a.s.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA S.A.
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
United States Vaccine Market Report and Forecast 2024-2032 - Product Image

United States Vaccine Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • United States
From
North America Vaccines Market Outlook, 2028 - Product Image

North America Vaccines Market Outlook, 2028

  • Report
  • 101 Pages
  • North America
From
Vaccines Market - Global Forecast 2026-2032 - Product Image

Vaccines Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Feline Vaccines Global Market Report 2026 - Product Image

Feline Vaccines Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.